Soy and metabolic Syndrome

Phase 2

• Conditions: Condition 1: Metabolic Syndrome. Condition 2: Metabolic Syndrome. Condition 3: Metabolic Syndrome.; Atherosclerotic heart disease; Non-insulin-dependent diabetes mellitus; Hypertensive heart disease

• Registration Number: IRCT138804212130N1
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 75

Inclusion Criteria

Inclusion Criteria: Women, age 60-70 years, BMI between 18.5-29, having at least three criteria of diagnostic criteria of MS, diagnosis of Metabolic syndrome according to the latest update of ATP-III (1. Waist circumference = 80 cm 2. TG = 150 mg/dl 3. HDL < 50 mg/dl 4. FPG = 101 mg/dl 5, blood pressure = 130/85)
Exclusion criteria: Current or previous estrogen therapy (in the preceding 6 mo), use of soy products or supplements (at least once per week for last 3 month), treatment with insulin or oral hypoglycemic, antilipemic, or hypertensive agents, treatment for Ischemic heart disease, vegetarian diet (more than six months), smoking (for 3 mo), antibiotic therapy (for last 3 month), documented hyper or hypothyroidism, presence of kidney or liver diseases, breast cancer or any other cancer, the history of CVD, in hearing or mental problem (not able to establish a communication ), or allergy to soy

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified